A:During a short scan, the device’s multimodal optical system captures facial and subcutaneous biological signals. The FEIPU X-FACE computational-biology model then analyzes these signals and estimates selected indicators related to metabolism and wellness.

A:This approach is different from a blood test, which directly measures chemical concentrations in a blood sample. FEIPU VitaMirror is an optical, non-contact assessment technology rather than a biochemical test. Scanning quality, lighting, facial occlusion, individual characteristics, and the approved model version can all affect the result.

A:No. The current FEIPU VitaMirror is a consumer-facing, non-contact health-screening and risk-assessment device. It is not a medical device and is not intended to diagnose, treat, cure, or prevent disease.

A: Results are for wellness-reference and trend-monitoring purposes only. They do not replace hospital laboratory tests, clinical examination, or professional medical advice. If the company obtains medical-device registration in a given market in the future, the applicable indications, report format, and user instructions for that market will be updated accordingly.

A:No. FEIPU VitaMirror does not replace blood tests, blood-glucose meters, blood-pressure monitors, or any other medical device.

It is designed to provide non-contact, convenient wellness screening and trend awareness. Blood tests remain the appropriate method for comprehensive biochemical examination. A practical approach is to use FEIPU VitaMirror for frequent daily wellness checks and blood tests for periodic, comprehensive medical review as recommended by a healthcare professional.

Depending on the product model and local configuration, FEIPU VitaMirror may estimate indicators such as blood glucose, triglycerides, high-density lipoprotein, blood pressure, hemoglobin, uric acid, obesity index, and skin age.

The actual indicator set varies by model, region, and software version. Skin age reflects an estimate of biological aging based on multiple metabolic and skin-related signals; it is not a diagnosis of any disease. Indicators under internal development, such as certain renal or liver-function indicators, should not be described as commercially available until validation and release are complete.

The company states that the model is developed against hospital laboratory-test data and that the overall average AUC is above 0.85, with some indicators, such as triglycerides and hemoglobin, reaching approximately 0.95 in selected validation comparisons.

Accuracy may vary by indicator, population, age group, skin characteristics, lighting, and device configuration. Detailed validation samples, correlation data, and limitations are available under a non-disclosure agreement. Results should therefore be understood as wellness references rather than fixed medical measurements.

A: FEIPU VitaMirror is intended for non-clinical wellness-awareness use. It should not be used by people who require clinical diagnosis or emergency medical assessment.

A: People with known or suspected medical conditions, pregnant users, minors, and anyone making important medical decisions should consult a qualified healthcare professional. If a result is unusual or does not feel consistent with your health status, seek medical testing and advice. The device is not an emergency device and must not be used to delay diagnosis or treatment.

A: Facial images, scan data, and wellness reports are handled under FEIPU’s Privacy Policy. The company uses encryption, access controls, and data-management measures designed to protect user information.

A: Personal facial data is not automatically shared with employers, venue operators, or third parties without an appropriate legal basis and user consent. Enterprise administrators can access only the data permitted by the service configuration. Users should review the applicable Privacy Policy for information about collection, storage, retention, deletion, and cross-border data transfer.

A: Personal health records are encrypted and stored on servers in the product’s sales country or region, in accordance with applicable privacy laws. Local deployment is available for selected projects, including sensitive environments, so that data remains within the customer’s internal network.

A: Users may export historical data through the supported application or terminal where this function is enabled. Specific storage locations and local-deployment options should be confirmed for each project and country.

A: Facial alignment and scanning usually take about 5–10 seconds, and a report is normally generated within about 60 seconds. The company describes the total experience as approximately 10 seconds for scanning and 60 seconds for a report.

A: Actual time may vary with network conditions, image quality, server response, and the user’s location. If lighting, movement, or facial obstruction interferes with the scan, the system may ask the user to repeat the measurement.

A: The device should be used indoors with stable lighting, away from strong direct sunlight, colored lighting, or other environmental interference. The user should remove glasses and masks, expose the forehead and ears, keep the face clean, and avoid heavy makeup where possible.

A: Hair, hats, scarves, and high collars that cover the forehead or ears should be removed or moved aside. The user should remain still and avoid talking, laughing, or making large facial movements during the scan. For semi-outdoor or brightly lit environments, the company can provide shading solutions and optical-adaptation options.